Geron Drug Patent Portfolio
Geron owns 1 orange book drug protected by 4 US patents Given below is the list of Geron's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9375485 | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms | 15 Mar, 2033 | Active |
| US7494982 | Modified oligonucleotides for telomerase inhibition | 27 Dec, 2025 | Active |
| US9388415 | Modified oligonucleotides for telomerase inhibition | 09 Sep, 2024 | Expired |
| US9388416 | Modified oligonucleotides for telomerase inhibition | 09 Sep, 2024 | Expired |
Geron's Family Patents
Geron Drug List
Given below is the complete list of Geron's drugs and the patents protecting them.
1. Rytelo
Rytelo is protected by 4 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9375485 | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms |
15 Mar, 2033
(8 years from now)
| Active |
| US7494982 | Modified oligonucleotides for telomerase inhibition |
27 Dec, 2025
(1 year, 1 month from now)
| Active |
| US9388415 | Modified oligonucleotides for telomerase inhibition |
09 Sep, 2024
(2 months ago)
| Expired |
| US9388416 | Modified oligonucleotides for telomerase inhibition |
09 Sep, 2024
(2 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rytelo's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List